BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16336625)

  • 21. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
    J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.
    Hirata Y; Meguro T; Kiuchi K
    J Neurochem; 2006 Oct; 99(2):416-25. PubMed ID: 17029596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
    Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
    Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
    Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway.
    Sun S; Li F; Gao X; Zhu Y; Chen J; Zhu X; Yuan H; Gao D
    Neuroscience; 2011 Dec; 199():359-67. PubMed ID: 22020319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.
    Guerreiro S; Toulorge D; Hirsch E; Marien M; Sokoloff P; Michel PP
    Mol Pharmacol; 2008 Oct; 74(4):980-9. PubMed ID: 18621927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.
    Zhang L; Fletcher-Turner A; Marchionni MA; Apparsundaram S; Lundgren KH; Yurek DM; Seroogy KB
    J Neurochem; 2004 Dec; 91(6):1358-68. PubMed ID: 15584912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells.
    Arboleda G; Huang TJ; Waters C; Verkhratsky A; Fernyhough P; Gibson RM
    Eur J Neurosci; 2007 May; 25(10):3030-8. PubMed ID: 17561816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
    Manáková S; Singh A; Kääriäinen T; Taari H; Kulkarni SK; Männistö PT
    Brain Res; 2005 Mar; 1038(1):83-91. PubMed ID: 15748876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.
    Leak RK; Liou AK; Zigmond MJ
    J Neurochem; 2006 Nov; 99(4):1151-63. PubMed ID: 16956375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.
    Bahat-Stroomza M; Gilgun-Sherki Y; Offen D; Panet H; Saada A; Krool-Galron N; Barzilai A; Atlas D; Melamed E
    Eur J Neurosci; 2005 Feb; 21(3):637-46. PubMed ID: 15733082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
    Carrasco E; Casper D; Werner P
    J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage.
    Liu B; Qin L; Yang SN; Wilson BC; Liu Y; Hong JS
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1133-41. PubMed ID: 11504811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells.
    Ajjimaporn A; Swinscoe J; Shavali S; Govitrapong P; Ebadi M
    Brain Res Bull; 2005 Nov; 67(6):466-75. PubMed ID: 16216695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
    J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.